DR Matthew Choy
Senior Research Fellow, Inflammatory Bowel Disease
Department of Medicine
90 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series
DOI: 10.1002/jgh3.704432026
Journal article
2026
Journal article
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department
DOI: 10.1007/s10620-026-09786-w2026
Journal article
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis
DOI: 10.1093/ibd/izag0422026
Journal article
2026
Journal article
Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemic
DOI: 10.1111/imj.703892026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.020
RECENT SCHOLARLY WORKS
2026
Journal article
P0684 Rethinking the Dose: A Bayesian Meta-Analysis of Infliximab Intensification in Acute Severe Ulcerative Colitis
DOI: 10.1093/ecco-jcc/jjaf231.8652025
Journal article
Editorial: Redefining Safety in Post-Liver Transplant IBD—Why Therapeutic Effectiveness Is the Ultimate Shield. Authors' Reply
DOI: 10.1111/apt.703412025
Journal article
Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation
DOI: 10.1111/apt.70283